Transfusion

The RCPAQAP Transfusion discipline covers all routine tests performed in a pre-transfusion testing laboratory including clinical decision making on given scenarios. The Individual Assessment program is designed to assist laboratory supervisors in maintaining and assess individual staff competencies while also enabling individual staff to meet EQA participation requirements as stipulated by the guidelines. The Foetal Maternal Haemorrhage Estimation program is for assessing laboratories on methods used in estimating foetal red cells in maternal samples.

Are you outside Australia?

Find your local distributor

ABO Titration

Catalogue Number

19170102

Frequency (No of surveys/year)

2

Cases/samples per survey

3

Sample Type

Plasma and red cells

Sample volume

4mL Plasma, 2 mL red cells

Schedule

January, October

Measurand/Test

anti-A titre, anti-B titre

Storage and Handling

Store samples at 2-8°C. RCPAQAP Transfusion samples must be tested within five (5) days of receipt because they are liable to haemolysis on prolonged storage. Some degree of haemolysis can be expected in the survey material, however based on historical records, there has been no negative effect in performance for participants reporting results on mild to moderately haemolysed survey samples. A haemolysis index diagram is provided.

Additional Comments

Designed for laboratories that performed BMT, Kidney and other solid organ donation with an ABO mismatched.
Report displayed will be according to clinical stream (i.e. BMT or Kidney)
Red cells closely represent actual patient samples
 

Product details last updated on December 12, 2023

Antibody Titre

The aim of this program is to assess the level of anti-D titre in the sample

Catalogue Number

19030102

Frequency (No of surveys/year)

4

Cases/samples per survey

1

Sample Type

Plasma

Sample volume

2mL

Schedule

March, May, July, September

Measurand/Test

Anti-D Titre

Storage and Handling

Store samples at 2-8°C. RCPAQAP Transfusion samples must be tested within five (5) days of receipt because they are liable to haemolysis on prolonged storage. Some degree of haemolysis can be expected in the survey material, however based on historical records, there has been no negative effect in performance for participants reporting results on mild to moderately haemolysed survey samples. A haemolysis index diagram is provided.

Product details last updated on January 10, 2023

Basic Compatibility

This program is based on various clinical scenarios. Based on the clinical scenario, participants are required to perform blood group, antibody screen, DAT and crossmatch

Catalogue Number

19040102

Frequency (No of surveys/year)

6

Cases/samples per survey

Variable

Sample Type

EDTA whole blood and red cells

Sample volume

4mL and 2mL

Schedule

January, March, May, July, September, November

Measurand/Test

Blood grouping, Antibody screen, Crossmatch/ compatibility testing, DAT

Storage and Handling

Store samples at 2-8°C. RCPAQAP Transfusion samples must be tested within five (5) days of receipt because they are liable to haemolysis on prolonged storage. Some degree of haemolysis can be expected in the survey material, however based on historical records, there has been no negative effect in performance for participants reporting results on mild to moderately haemolysed survey samples. A haemolysis index diagram is provided.

Product details last updated on May 18, 2023

Blood Grouping and Antibody Screen/Identification

The aim of this program is to assess blood grouping only or antibody screen and identification.

Catalogue Number

19010102

Frequency (No of surveys/year)

6

Cases/samples per survey

2

Sample Type

EDTA whole blood

Sample volume

6mL

Schedule

February, March, June, August, October, November

Measurand/Test

Blood grouping, Antibody Screen/Identification – Optional

Storage and Handling

Store samples at 2-8°C. RCPAQAP Transfusion samples must be tested within five (5) days of receipt because they are liable to haemolysis on prolonged storage. Some degree of haemolysis can be expected in the survey material, however based on historical records, there has been no negative effect in performance for participants reporting results on mild to moderately haemolysed survey samples. A haemolysis index diagram is provided.

Product details last updated on August 31, 2022

Fetomaternal Haemorrhage

The aim of this program is to assess percentage and volume of fetal cells and the number of anti-D vials.

Catalogue Number

19020102

Frequency (No of surveys/year)

4

Cases/samples per survey

2

Sample Type

EDTA whole blood

Sample volume

2mL

Schedule

February, March, August, October

Measurand/Test

Fetomaternal Haemorrhage Estimation

Storage and Handling

Store samples at 2-8°C. RCPAQAP Transfusion samples must be tested within 72 hours of receipt because they are liable to haemolysis on prolonged storage. Some degree of haemolysis can be expected in the survey material, however based on historical records, there has been no negative effect in performance for participants reporting results on mild to moderately haemolysed survey samples. A haemolysis index diagram is provided.

Product details last updated on January 9, 2023

General Compatibility

This program is based on various clinical scenarios.

Catalogue Number

19050102

Frequency (No of surveys/year)

6

Cases/samples per survey

Variable

Sample Type

EDTA whole blood and red cells

Sample volume

4mL and 2mL

Schedule

January, March, May, July, September, November

Measurand/Test

Blood grouping, Antibody screen, Antibody identification, Crossmatch/ compatibility testing, Phenotyping, DAT, Elution studies.

Storage and Handling

Store samples at 2-8°C. RCPAQAP Transfusion samples must be tested within five (5) days of receipt because they are liable to haemolysis on prolonged storage. Some degree of haemolysis can be expected in the survey material, however based on historical records, there has been no negative effect in performance for participants reporting results on mild to moderately haemolysed survey samples. A haemolysis index diagram is provided.

Product details last updated on May 18, 2023

Haemolytic Disease of the Newborn

What's new

New for 2025

Catalogue Number

19180102

Frequency (No of surveys/year)

2

Cases/samples per survey

2

Sample Type

EDTA whole blood and EDTA plasma

Sample volume

2mL

Schedule

June, November

Measurand/Test

Blood grouping, antibody screen, antibody identification, DAT, elution studies

Storage and Handling

Store samples at 2-8°C. RCPAQAP Transfusion samples must be tested within five (5) days of receipt because they are liable to haemolysis on prolonged storage. Some degree of haemolysis can be expected in the survey material, however based on historical records, there has been no negative effect in performance for participants reporting results on mild to moderately haemolysed survey samples. A haemolysis index diagram is provided.

Product details last updated on September 6, 2024

Phenotyping

The aim of this program is to assess on results for antisera held in laboratories.

Catalogue Number

19060102

Frequency (No of surveys/year)

4

Cases/samples per survey

1

Sample Type

EDTA whole blood

Sample volume

4mL

Schedule

March, May, July, September

Measurand/Test

Extended Red Cell Antigen Phenotyping

Storage and Handling

Store samples at 2-8°C. RCPAQAP Transfusion samples must be tested within five (5) days of receipt because they are liable to haemolysis on prolonged storage. Some degree of haemolysis can be expected in the survey material, however based on historical records, there has been no negative effect in performance for participants reporting results on mild to moderately haemolysed survey samples. A haemolysis index diagram is provided.

Product details last updated on January 10, 2023

Snake Venom Detection

A dry swab is supplied for the detection of Australian snake venom.

Catalogue Number

19080102

Frequency (No of surveys/year)

1

Cases/samples per survey

1

Sample Type

Swab

Sample volume

n/a

Schedule

September

Measurand/Test

Snake venom detection

Storage and Handling

Samples should be stored at 2-8°C. RCPAQAP Transfusion samples must be tested within five (5) days of receipt.

Product details last updated on July 31, 2020

Transfusion Competency – Antibody Identification Module (Overseas participants only)

The aim of this program is to assess antibody identification

Catalogue Number

19090102

Frequency (No of surveys/year)

6

Cases/samples per survey

1

Sample Type

EDTA whole blood

Sample volume

4mL

Schedule

February, March, June, August, October, November

Measurand/Test

Antibody identification

Storage and Handling

Store samples at 2-8°C. RCPAQAP Transfusion samples must be tested within five (5) days of receipt because they are liable to haemolysis on prolonged storage. Some degree of haemolysis can be expected in the survey material, however based on historical records, there has been no negative effect in performance for participants reporting results on mild to moderately haemolysed survey samples. A haemolysis index diagram is provided.

Product details last updated on August 31, 2022

Transfusion Competency – Antibody Screen Module (Overseas participants only)

Catalogue Number

19100102

Frequency (No of surveys/year)

6

Cases/samples per survey

1

Sample Type

EDTA whole blood

Sample volume

4mL

Schedule

February, March, June, August, October, November

Measurand/Test

Antibody screen

Storage and Handling

Store samples at 2-8°C. RCPAQAP Transfusion samples must be tested within five (5) days of receipt because they are liable to haemolysis on prolonged storage. Some degree of haemolysis can be expected in the survey material, however based on historical records, there has been no negative effect in performance for participants reporting results on mild to moderately haemolysed survey samples. A haemolysis index diagram is provided.

Product details last updated on August 31, 2022

Transfusion Competency – Blood Grouping Module (Overseas participants only)

The aim of this program is to assess blood grouping

Catalogue Number

19110102

Frequency (No of surveys/year)

6

Cases/samples per survey

3

Sample Type

EDTA whole blood and red cells

Sample volume

4mL and 2mL

Schedule

February, March, June, August, October, November

Measurand/Test

Blood grouping

Storage and Handling

Store samples at 2-8°C. RCPAQAP Transfusion samples must be tested within five (5) days of receipt because they are liable to haemolysis on prolonged storage. Some degree of haemolysis can be expected in the survey material, however based on historical records, there has been no negative effect in performance for participants reporting results on mild to moderately haemolysed survey samples. A haemolysis index diagram is provided.

Product details last updated on November 14, 2022

Transfusion Competency – Crossmatching / Compatibility Testing Module (Overseas participants only)

The aim of this program is to assess crossmatching

Catalogue Number

19120102

Frequency (No of surveys/year)

6

Cases/samples per survey

3

Sample Type

1 EDTA Whole Blood, 2 red cells donor units

Sample volume

4mL + 2mL

Schedule

February, March, June, August, October, November

Measurand/Test

Crossmatching / Compatibility Testing

Storage and Handling

Store samples at 2-8°C. RCPAQAP Transfusion samples must be tested within five (5) days of receipt because they are liable to haemolysis on prolonged storage. Some degree of haemolysis can be expected in the survey material, however based on historical records, there has been no negative effect in performance for participants reporting results on mild to moderately haemolysed survey samples. A haemolysis index diagram is provided.

Product details last updated on August 31, 2022

Transfusion Competency – DAT Module (Overseas participants only)

The aim of this program is to assess DAT

Catalogue Number

19130102

Frequency (No of surveys/year)

6

Cases/samples per survey

1

Sample Type

EDTA red cells

Sample volume

2mL

Schedule

February, March, June, August, October, November

Measurand/Test

DAT

Storage and Handling

Store samples at 2-8°C. RCPAQAP Transfusion samples must be tested within five (5) days of receipt because they are liable to haemolysis on prolonged storage. Some degree of haemolysis can be expected in the survey material, however based on historical records, there has been no negative effect in performance for participants reporting results on mild to moderately haemolysed survey samples. A haemolysis index diagram is provided.

Product details last updated on August 31, 2022

Transfusion Competency – Full Program (Overseas participants only)

Participants select which tests they would like to perform from the Transfusion Competency Modules

Catalogue Number

19160102

Frequency (No of surveys/year)

6

Sample Type

EDTA whole blood and red cells

Sample volume

4mL and 2mL

Schedule

February, March, June, August, October, November

Storage and Handling

Store samples at 2-8°C. RCPAQAP Transfusion samples must be tested within five (5) days of receipt because they are liable to haemolysis on prolonged storage. Some degree of haemolysis can be expected in the survey material, however based on historical records, there has been no negative effect in performance for participants reporting results on mild to moderately haemolysed survey samples. A haemolysis index diagram is provided.

Product details last updated on October 3, 2023

Transfusion Competency – Phenotyping (Rh / K antigens only) Module (Overseas participants only)

The aim of this program is to assess Rh/K antigens

Catalogue Number

19140102

Frequency (No of surveys/year)

6

Cases/samples per survey

3

Sample Type

EDTA whole blood and red cells

Sample volume

4mL and 2mL

Schedule

February, March, June, August, October, November

Measurand/Test

Phenotyping (Rh/ K antigens only)

Storage and Handling

Store samples at 2-8°C. RCPAQAP Transfusion samples must be tested within five (5) days of receipt because they are liable to haemolysis on prolonged storage. Some degree of haemolysis can be expected in the survey material, however based on historical records, there has been no negative effect in performance for participants reporting results on mild to moderately haemolysed survey samples. A haemolysis index diagram is provided.

Product details last updated on August 31, 2022

  Back to products

<

>